Area of research
Pathology and Forensic Medicine · Epidemiology
Research interest
Research interests include Alcohol Consumption and Health Effects, Liver Disease Diagnosis and Treatment, Liver physiology and pathology, and Adipose Tissue and Metabolism.
The Link between Alcohol Consumption and Kidney Injury.
Hyaluronan 35 prevents endotoxin-mediated dysregulated skeletal muscle proteostasis during ethanol exposure.
Gut microbe-derived <i>N</i>-acyl serinol lipids shape host postprandial metabolic homeostasis.
RIP3 and MLKL regulate ER stress in alcohol-associated liver disease and pharmacological ER stress models: Insights beyond necroptosis
Fibrosis: cross-organ biology and pathways to development of innovative drugs.
Publisher Correction: Fibrosis: cross-organ biology and pathways to development of innovative drugs.
Genomic approaches to explore susceptibility and pathogenesis of alcohol use disorder and alcohol-associated liver disease.
Exome-wide association analysis identifies novel risk loci for alcohol-associated hepatitis.
Chronic Alcohol Consumption Reprograms Hepatic Metabolism Through Organelle-Specific Acetylation in Mice
Prorenin in Hepatic Stellate Cell Extracellular Vesicles Induces Platelet-Dependent Thrombin Formation and Release of Profibrotic TGF-β.
35k Da specific-sized hyaluronan ameliorates high-fat diet-induced liver injury in murine model of moderate obesity
Reply to 'Incorporating genetic variations in alcohol-associated liver disease trials for East Asian populations'.
Author Correction: Hyaluronic acid 35 normalizes TLR4 signaling in Kupffer cells from ethanol-fed rats via regulation of microRNA291b and its target Tollip.
Evidence that extracellular HSPB1 contributes to inflammation in alcohol-associated hepatitis.
Gut-liver axis: Recent concepts in pathophysiology in alcohol-associated liver disease
Mediators of necroptosis: from cell death to metabolic regulation.
Randomized trial of anakinra plus zinc vs. prednisone for severe alcohol-associated hepatitis.
Gut-liver axis: Recent concepts in pathophysiology in alcohol-associated liver disease.
Designing clinical trials to address alcohol use and alcohol-associated liver disease: an expert panel Consensus Statement.
Hyperglycemic environments directly compromise intestinal epithelial barrier function in an organoid model and hyaluronan (∼35 kDa) protects via a layilin dependent mechanism
Proteomics identifies complement protein signatures in patients with alcohol-associated hepatitis.
Author Correction: Mediators of necroptosis: from cell death to metabolic regulation.
Reply to 'An expert panel Consensus Statement on ALD without experts by experience'.
The pyruvate dehydrogenase kinase inhibitor dichloroacetate mitigates alcohol-induced hepatic inflammation and metabolic disturbances in mice.
Safety, Pharmacokinetics, and Efficacy Signals of Larsucosterol (DUR-928) in Alcohol-Associated Hepatitis
Alcohol-induced extracellular ASC specks perpetuate liver inflammation and damage in alcohol-associated hepatitis even after alcohol cessation.
35kDa hyaluronan ameliorates ethanol driven loss of anti-microbial defense and intestinal barrier integrity in a TLR4-dependent manner
Mincle-GSDMD-mediated release of IL-1β small extracellular vesicles from hepatic macrophages in ethanol-induced liver injury.
5S rRNA pseudogene transcripts are associated with interferon production and inflammatory responses in alcohol-associated hepatitis.
A genetic risk score and diabetes predict development of alcohol-related cirrhosis in drinkers.